Jappe U, Raulf-Heimsoth M, Hoffmann M, Burow G, Hübsch-Müller C, Enk A
Department of Dermatology and Venereology, University of Heidelberg, Heidelberg, Germany.
Allergy. 2006 Oct;61(10):1220-9. doi: 10.1111/j.1398-9995.2006.01232.x.
Immunoglobulin (Ig) E-double positivity for honeybee (HB) and yellow jacket (YJ) venom causes diagnostic difficulties concerning therapeutical strategies. The aim of this study was to clarify the cause and relation of the cross-reactivity in patients with insect venom allergy.
For this purpose, 147 patients with suspected stinging insect allergy and CAP-FEIA-double positivity were investigated for specific sIgE to additional cross-reactive carbohydrate determinant (CCD)-containing allergens: timothy grass pollen, rape pollen, natural rubber latex (NRL), bromelain, and horseradish peroxidase (HRP). Sera with sIgE to NRL were further investigated with the commercially available recombinant latex allergens. Reciprocal inhibition assays with both venoms and HRP were performed.
About 36 of 147 (24.5%) patients had sIgE to both venoms only. However, 111 of 147 (75.5%) additionally reacted to CCD-carrying allergens. 89 of 111 CCD-reactive sera had NRL-sIgE. In cases where inhibition experiments were performed, the NRL-sIgE binding was completely abolished in the presence of HRP. Only nine of 61 sera were positive for at least one recombinant latex allergen; all of them were negative in history and NRL-skin prick test. In 43 sera containing sIgE to CCD, HRP inhibition revealed unequivocal results: In 28 of 43 (65%) an HRP-inhibition >70% of sIgE to one venom occurred, pointing out the relevant venom. In three of 43 sIgE proved to be entirely CCD-specific.
Our data indicate that in cases of IgE positivity to both insect venoms supplementary screening tests with at least one CCD-containing allergen should be performed; HRP being a suitable tool for this test. In addition, subsequent reciprocal inhibition is an essential diagnostic method to specify cross-reacting sIgE results.
对蜜蜂(HB)和黄蜂(YJ)毒液呈免疫球蛋白(Ig)E双阳性会给治疗策略的诊断带来困难。本研究的目的是阐明昆虫毒液过敏患者交叉反应的原因及关系。
为此,对147例疑似蜇刺昆虫过敏且CAP-FEIA双阳性的患者进行了检测,以确定其针对其他含交叉反应性碳水化合物决定簇(CCD)的过敏原的特异性sIgE,这些过敏原包括:梯牧草花粉、油菜花粉、天然橡胶乳胶(NRL)、菠萝蛋白酶和辣根过氧化物酶(HRP)。对含有针对NRL的sIgE的血清,进一步使用市售重组乳胶过敏原进行检测。用毒液和HRP进行了双向抑制试验。
147例患者中约36例(24.5%)仅对两种毒液有sIgE。然而,147例中有111例(75.5%)还对携带CCD的过敏原产生反应。111例对CCD有反应的血清中,89例有针对NRL的sIgE。在进行抑制实验的病例中,在HRP存在的情况下,NRL-sIgE结合被完全消除。61例血清中只有9例对至少一种重组乳胶过敏原呈阳性;所有这些患者既往史和NRL皮肤点刺试验均为阴性。在43份含有针对CCD的sIgE的血清中,HRP抑制显示出明确的结果:43例中有28例(65%)对一种毒液的sIgE的HRP抑制率>70%,表明该毒液具有相关性。43例中有3例的sIgE被证明完全是CCD特异性的。
我们的数据表明,对于两种昆虫毒液IgE均呈阳性的病例,应使用至少一种含CCD的过敏原进行补充筛查试验;HRP是该试验的合适工具。此外,后续的双向抑制是明确交叉反应性sIgE结果的重要诊断方法。